205 related articles for article (PubMed ID: 30426810)
1. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East.
Abanmi A; Al-Enezi M; Al Hammadi A; Galadari I; Kibbi AG; Zimmo S
J Dermatolog Treat; 2019 Sep; 30(6):578-581. PubMed ID: 30426810
[No Abstract] [Full Text] [Related]
2. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation.
Abad-Casintahan F; Chow SK; Goh CL; Kubba R; Hayashi N; Noppakun N; See J; Suh DH; Xiang LH; Kang S;
J Dermatol; 2016 Jul; 43(7):826-8. PubMed ID: 26813513
[TBL] [Abstract][Full Text] [Related]
3. Evaluating acne-related post-inflammatory hyperpigmentation is a challenge even amongst experts.
Goh CL; Abad-Casintahan F; Chow SK; Kubba R; Miyachi Y; Noppakun N; See J; Suh DH; Xiang LF; Kang S;
J Dermatol; 2014 Dec; 41(12):1106-8. PubMed ID: 25327447
[TBL] [Abstract][Full Text] [Related]
4. Trichloroacetic acid model to accurately capture the efficacy of treatments for postinflammatory hyperpigmentation.
Lyons AB; Kohli I; Nahhas AF; Braunberger TL; Mohammad TF; Nicholson CL; Nartker NT; Modi K; Matsui MS; Lim HW; Hamzavi IH
Arch Dermatol Res; 2020 Dec; 312(10):725-730. PubMed ID: 32253506
[TBL] [Abstract][Full Text] [Related]
5. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris.
Savory SA; Agim NG; Mao R; Peter S; Wang C; Maldonado G; Bearden Dietert J; Lieu TJ; Wang C; Pretzlaff K; Das S; Vandergriff T; Lopez IE; Litzner BR; Hynan LS; Arellano-Mendoza MI; Bergstresser PR; Pandya AG
J Am Acad Dermatol; 2014 Jan; 70(1):108-14. PubMed ID: 24176524
[TBL] [Abstract][Full Text] [Related]
6. An in vivo model for postinflammatory hyperpigmentation: an analysis of histological, spectroscopic, colorimetric and clinical traits.
Isedeh P; Kohli I; Al-Jamal M; Agbai ON; Chaffins M; Devpura S; Mahan M; Vanderover G; Lim HW; Matsui MS; Hamzavi IH
Br J Dermatol; 2016 Apr; 174(4):862-8. PubMed ID: 26663029
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel.
Amar L; Kircik LH
J Drugs Dermatol; 2018 Oct; 17(10):1107-1112. PubMed ID: 30365592
[TBL] [Abstract][Full Text] [Related]
8. Getting to the Core of Contemporary Therapies for Post-Inflammatory Hyperpigmentation.
Naik P
J Drugs Dermatol; 2022 Mar; 21(3):276-283. PubMed ID: 35254763
[TBL] [Abstract][Full Text] [Related]
9. Effects of Topical Retinoids on Acne and Post-inflammatory Hyperpigmentation in Patients with Skin of Color: A Clinical Review and Implications for Practice.
Callender VD; Baldwin H; Cook-Bolden FE; Alexis AF; Stein Gold L; Guenin E
Am J Clin Dermatol; 2022 Jan; 23(1):69-81. PubMed ID: 34751927
[TBL] [Abstract][Full Text] [Related]
10. Treating acne scars in patients with Fitzpatrick skin types IV to VI using the 1450-nm diode laser.
Semchyshyn N; Prodanovic E; Varade R
Cutis; 2013 Jul; 92(1):49-53. PubMed ID: 23961527
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of azelaic acid (AzA) gel 15% in the treatment of post-inflammatory hyperpigmentation and acne: a 16-week, baseline-controlled study.
Kircik LH
J Drugs Dermatol; 2011 Jun; 10(6):586-90. PubMed ID: 21637899
[TBL] [Abstract][Full Text] [Related]
12. Laser treatment of acne scarring in skin of colour.
Havelin A; Seukeran DC
Clin Exp Dermatol; 2023 Apr; 48(5):443-447. PubMed ID: 36763696
[TBL] [Abstract][Full Text] [Related]
13. Large-scale international study enhances understanding of an emerging acne population: adult females.
Dréno B; Thiboutot D; Layton AM; Berson D; Perez M; Kang S;
J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1096-106. PubMed ID: 25296739
[TBL] [Abstract][Full Text] [Related]
14. The Pathogenesis and Management of Acne-Induced Post-inflammatory Hyperpigmentation.
Elbuluk N; Grimes P; Chien A; Hamzavi I; Alexis A; Taylor S; Gonzalez N; Weiss J; Desai SR; Kang S
Am J Clin Dermatol; 2021 Nov; 22(6):829-836. PubMed ID: 34468934
[TBL] [Abstract][Full Text] [Related]
15. Tazarotene cream for postinflammatory hyperpigmentation and acne vulgaris in darker skin: a double-blind, randomized, vehicle-controlled study.
Grimes P; Callender V
Cutis; 2006 Jan; 77(1):45-50. PubMed ID: 16475496
[TBL] [Abstract][Full Text] [Related]
16. Skin microneedling for acne scars associated with pigmentation in patients with dark skin.
Al Qarqaz F; Al-Yousef A
J Cosmet Dermatol; 2018 Jun; 17(3):390-395. PubMed ID: 29543377
[TBL] [Abstract][Full Text] [Related]
17. A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians.
Eimpunth S; Wanitphadeedecha R; Manuskiatti W
J Eur Acad Dermatol Venereol; 2013 Jan; 27 Suppl 1():7-18. PubMed ID: 23205540
[TBL] [Abstract][Full Text] [Related]
18. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians.
Chan HH; Manstein D; Yu CS; Shek S; Kono T; Wei WI
Lasers Surg Med; 2007 Jun; 39(5):381-5. PubMed ID: 17518354
[TBL] [Abstract][Full Text] [Related]
19. Treatment of facial postinflammatory hyperpigmentation with facial acne in Asian patients using a Q-switched neodymium-doped yttrium aluminum garnet laser.
Kim S; Cho KH
Dermatol Surg; 2010 Sep; 36(9):1374-80. PubMed ID: 20629693
[TBL] [Abstract][Full Text] [Related]
20. A retrospective analysis of the management of acne post-inflammatory hyperpigmentation using topical treatment, laser treatment, or combination topical and laser treatments in oriental patients.
Ho SG; Yeung CK; Chan NP; Shek SY; Kono T; Chan HH
Lasers Surg Med; 2011 Jan; 43(1):1-7. PubMed ID: 21254136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
